Page last updated: 2024-08-26

cholesteryl butanoate and Prostatic Neoplasms

cholesteryl butanoate has been researched along with Prostatic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barrera, G; Chiocchetti, A; Conti, L; Dianzani, C; Dianzani, U; Fantozzi, R; Gasco, P; Gigliotti, CL; Giovarelli, M; Minelli, R; Occhipinti, S; Zara, GP	1

Other Studies

1 other study(ies) available for cholesteryl butanoate and Prostatic Neoplasms

Article	Year
Solid lipid nanoparticles of cholesteryl butyrate inhibit the proliferation of cancer cells in vitro and in vivo models. British journal of pharmacology, 2013, Volume: 170, Issue:2 Topics: Animals; Antineoplastic Agents; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cholesterol Esters; Colonic Neoplasms; Female; Humans; Lipids; Male; Mice; Mice, SCID; Nanoparticles; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Xenograft Model Antitumor Assays	2013

Article

Year

Solid lipid nanoparticles of cholesteryl butyrate inhibit the proliferation of cancer cells in vitro and in vivo models.

British journal of pharmacology, 2013, Volume: 170, Issue:2

Topics: Animals; Antineoplastic Agents; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cholesterol Esters; Colonic Neoplasms; Female; Humans; Lipids; Male; Mice; Mice, SCID; Nanoparticles; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Xenograft Model Antitumor Assays

2013